Literature DB >> 22088338

Population based analysis of the increasing incidence of kidney cancer in the United States: evaluation of age specific trends from 1975 to 2006.

Kenneth G Nepple1, Liu Yang, Robert L Grubb, Seth A Strope.   

Abstract

PURPOSE: An increase in kidney cancer was reported in the United States but overall rates may obscure trends in age specific groups. We explored whether the increase in kidney cancer incidence differs across age groups.
MATERIALS AND METHODS: We ascertained the 63,843 incident renal cancer cases in SEER (Surveillance, Epidemiology and End Results) cancer registries for 1975 to 2006. Yearly incidence rates of renal cancer were calculated and stratified by age group. Age specific trends in cancer diagnosis were evaluated by Poisson regression.
RESULTS: From 1975 to 2006 the overall age adjusted renal cancer incidence increased 238% from 7.4/100,000 to 17.6/100,000 adults. From 1991 to 2006 the mean age at diagnosis decreased from 64.7 to 62.7 years and the proportion of patients diagnosed before age 65 years increased from 45.9% to 55.3%. Age specific incidence rates of renal cancer increased in all age groups from 1975 to 2006 (p <0.0001). However, the rates changed at different rates. Overall renal cancer diagnosis in the youngest age group (20 to 39 years) increased more quickly than all other age groups (p <0.0001). The renal cancer incidence in patients 60 to 69 and 70 to 79 years old increased more rapidly than in those 40 to 49 and 50 to 59 years old (p <0.01).
CONCLUSIONS: In the last 15 years mean age at diagnosis of renal cancer has decreased. During our study period the most rapidly increasing kidney cancer incidence was seen in those younger than 40 and 60 to 79 years old. The renal cancer increase in younger patients should direct attention toward further evaluation of renal cancer risk factors.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22088338     DOI: 10.1016/j.juro.2011.09.028

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  20 in total

1.  Effect of comorbidity on risk of venous thromboembolism in patients with renal cell carcinoma.

Authors:  Angela B Smith; Erzsébet Horvath-Puhó; Matthew E Nielsen; Timothy L Lash; John A Baron; Henrik T Sørensen
Journal:  Urol Oncol       Date:  2014-05       Impact factor: 3.498

2.  Kidney cancer incidence and mortality among American Indians and Alaska Natives in the United States, 1990-2009.

Authors:  Jun Li; Hannah K Weir; Melissa A Jim; Sallyann M King; Reda Wilson; Viraj A Master
Journal:  Am J Public Health       Date:  2014-04-22       Impact factor: 9.308

3.  Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.

Authors:  Jeremiah J Morrissey; Vincent M Mellnick; Jingqin Luo; Marilyn J Siegel; R Sherburne Figenshau; Sam Bhayani; Evan D Kharasch
Journal:  JAMA Oncol       Date:  2015-05       Impact factor: 31.777

Review 4.  IMA901: a multi-peptide cancer vaccine for treatment of renal cell cancer.

Authors:  Alexandra Kirner; Andrea Mayer-Mokler; Carsten Reinhardt
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  Impact of Robotic Fellowship Experience on Perioperative Outcomes of Robotic-Assisted Laparoscopic Partial Nephrectomy.

Authors:  Michael A Moriarty; Kenneth G Nepple; Chad R Tracy; Michael E Strigenz; Daniel K Lee; James A Brown
Journal:  Curr Urol       Date:  2016-02-10

6.  Urinary concentrations of aquaporin-1 and perilipin-2 in patients with renal cell carcinoma correlate with tumor size and stage but not grade.

Authors:  Jeremiah J Morrissey; Jonathan Mobley; Joseph Song; Joel Vetter; Jingqin Luo; Sam Bhayani; R Sherburne Figenshau; Evan D Kharasch
Journal:  Urology       Date:  2013-11-13       Impact factor: 2.649

Review 7.  Evaluation of renal masses with contrast-enhanced ultrasound.

Authors:  S Houtzager; H Wijkstra; J J M C H de la Rosette; M P Laguna
Journal:  Curr Urol Rep       Date:  2013-04       Impact factor: 3.092

8.  Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010.

Authors:  Sallyann Coleman King; Lori A Pollack; Jun Li; Jessica B King; Viraj A Master
Journal:  J Urol       Date:  2014-01-11       Impact factor: 7.450

9.  Age--an independent prognostic factor of clinical outcome in renal malignancies: results of a large study over two decades.

Authors:  Marie C Hupe; Axel S Merseburger; Vinata B Lokeshwar; Hendrik Eggers; Hendrik Rott; Gerd Wegener; Mahmoud Abbas; Markus A Kuczyk; Thomas R Herrmann
Journal:  World J Urol       Date:  2013-10-02       Impact factor: 4.226

10.  Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks model.

Authors:  Hiten D Patel; Max Kates; Phillip M Pierorazio; Mohamad E Allaf
Journal:  Urol Oncol       Date:  2014-03-12       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.